IGF2BP1 and neuroblastoma: With the amplification of the 17q chromosomal arm—including the IGF2BP1 gene locus—being one of the most common genetic alterations in neuroblastoma, and the linkage of IGF2BP1 expression serving as a prognosticator of poor prognosis (12, 24), we present evidence to support that IGF2BP1 is a promising novel therapeutic target for neuroblastoma.